|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2-3
|
|
pubmed:dateCreated |
2003-7-2
|
|
pubmed:abstractText |
Three randomized, placebo-controlled trials have demonstrated the safety and efficacy of levetiracetam, a new antiepileptic medication, as add-on therapy for partial-onset seizures. The purpose of this study was to gather additional safety and efficacy data on levetiracetam in the real-world setting of community-based practice.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0920-1211
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
153-61
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12837566-Adolescent,
pubmed-meshheading:12837566-Adult,
pubmed-meshheading:12837566-Aged,
pubmed-meshheading:12837566-Aged, 80 and over,
pubmed-meshheading:12837566-Anticonvulsants,
pubmed-meshheading:12837566-Community Health Services,
pubmed-meshheading:12837566-Drug Therapy, Combination,
pubmed-meshheading:12837566-Epilepsies, Partial,
pubmed-meshheading:12837566-Female,
pubmed-meshheading:12837566-Humans,
pubmed-meshheading:12837566-Male,
pubmed-meshheading:12837566-Middle Aged,
pubmed-meshheading:12837566-Piracetam,
pubmed-meshheading:12837566-Prospective Studies
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.
|
|
pubmed:affiliation |
The Neurological Institute, Columbia Presbyterian Medical Center, Columbia University, 710 West 168th Street, New York, NY, USA. mm978@columbia.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase IV
|
